Middle East Fertility Society Journal · 2010 · 33 citations · 4 references
MedicineMaternal HealthObstetricsMaternal-fetal MedicinePreterm BirthWomen's Health PharmacotherapyMaternal Disease PreventionPregnancyPreterm LaborProgesterone TherapyAntenatal Steroid EfficacyClinical Trial Of PreventionGestational Age MeasurementIntramuscular ProgesteronePlacebo ComparatorsPreterm Birth Risk ReductionPreterm Labor RiskRecurrent Preterm Birth Prevention
Objective: To evaluate the efficacy of intramuscular progesterone in prevention of preterm labor in high risk cases. Design: Randomized controlled trial. Setting: Ain Shams Maternity hospital. Materials and methods: Singleton pregnant women in their second trimester with a history of previous preterm labor were divided into two groups: progesterone group: received 17-α-hydroxy progesterone caproate (Cidolut depot) one dose of 250mg IM once weekly until 36weeks and placebo group: received standard dose of placebo IM per week. Follow up till delivery. Results: The mean gestational age was 37.4±1.5 in progesterone group vs. 34.7±2.4 in placebo group (P<0.05). In the progesterone group 8 of 25 women delivered before completion of 37 weeks of gestation (32%) and 17 women delivered full term (68%). In placebo group, 13 of 25 women delivered before completion of 37weeks of gestation (52%) and 12 women delivered full term (48%). Conclusion: Our findings support 17-α-hydroxy progesterone as a successful drug in the prevention and decreasing the rate of recurrent preterm labor.
4
Eduardo Borges da Fonseca, Roberto Eduardo Bittar, Mário Henrique Burlacchini de Carvalho et al. · American Journal of Obstetrics and Gynecology · 2003 · 794 citations
Medicine, Gynecology, Obstetrics +15